Palo Alto Networks, Inc. (Nasdaq: PANW) published its financial results for the third quarter of fiscal year 2023, with adjusted earnings per share of $1.10, outperforming the consensus estimate of $0.93. The company also provided forward-looking guidance, raising its cash flow margin and operating margin expectations for the fiscal year 2023, reflecting its confidence in current market conditions.

In pre-market, $PANW is trading at $198.10, indicating a notable gain of $8.36 or 4.41%.

Urban Outfitters, Inc. (Nasdaq: URBN) reported exceptional performance in the first quarter, achieving record sales and earnings per share. The company attributed this success to a 5% increase in comparable Retail segment sales, strong growth in Nuuly Rent, and a substantial improvement in gross margins. For the three months ending April 30, 2023, Urban Outfitters reported earnings per share of $0.56, surpassing the consensus estimate of $0.35.

$URBN is trading at $29.79 in pre-market, representing a significant increase of $3.13 or 11.74%.

Inovio Pharmaceuticals, Inc. (Nasdaq: INO) shared positive news regarding its product candidate, INO-3107, designed to treat Recurrent Respiratory Papillomatosis (RRP), a rare and debilitating disease primarily caused by HPV-6 and/or HPV-11. The European Commission (EC) granted INO-3107 orphan drug designation, highlighting its potential to address this challenging medical condition. INO-3107 is an investigational DNA medicine candidate engineered to elicit a targeted T cell response against HPV-6 and HPV-11, which are the key culprits behind RRP and other HPV-related diseases.

In pre-market, $INO is currently trading at $0.74 (up $0.08 or 12.56%).

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)